Scholarlink

Background <p>While intravenous iron improves outcomes in anaemic surgical patients, the impact of iron deficiency (ID) and its treatment in non-anaemic patients remains unclear.</p> Methods <p>In this single-centre retrospective analysis, non-anaemic ID patients (age ≥ 18&#xa0;years) undergoing major cardiac surgery at the University Hospital Frankfurt were included. Primary endpoints were red blood cell (RBC) transfusion rate and use of RBC units. Secondary endpoints were increase in haemoglobin levels and postoperative outcome (mortality, length of stay, mechanical ventilation, laboratory values). Patients were assigned to the following groups: No-Iron (no anaemia, ID, and no iron supplementation) and Iron (anaemia, ID, and iron supplementation).</p> Results <p>A total of 3605 patients were screened, of whom 2345 were non-anaemic. Six hundred ninety-eight non-anaemic ID patients were included in the analysis, of whom 90 received intravenous iron supplementation. The overall RBC transfusion rate (43.6% [95% CI: 39.6–47.6] versus 50.0% [95% CI: 39.9–60.1]) and number of transfused blood units (2.0 [IQR: 1.0; 4.0] versus 2.0 [IQR: 1.0; 4.0]) were similar between patients of the No-Iron and Iron groups. Hospital length of stay, mortality, and postoperative complications were similar in both groups. When applying stricter cutoff values to define ID (ferritin &lt; 30&#xa0;μg/l), a trend toward reduced transfusion rates was observed: total RBC transfusion rate was 50.0% (95% CI: 34.9–65.2) in the No-Iron group and 42.9% (95% CI: 26.8–60.5) in the Iron group. In the case of short-term (1&#xa0;day prior to surgery) iron supplementation, RBC unit utilisation and postoperative outcomes were comparable between the two groups.</p> Conclusion <p>In non-anaemic cardiac surgery patients, (short-term) preoperative intravenous iron supplementation showed no significant impact on RBC transfusion rate, haemoglobin levels, or postoperative outcomes. However, a stricter definition of ID revealed a trend toward reduced transfusion rates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of (short-term) intravenous iron supplementation in iron-deficient non-anaemic cardiac surgical patients on perioperative outcome

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月13日

查看全文
  • Lea Valeska Blum,
  • Nico Hipp,
  • Vanessa Neef,
  • Anatol Prinzing,
  • Kai Zacharowski,
  • Patrick Meybohm,
  • Suma Choorapoikayil

摘要

Background

While intravenous iron improves outcomes in anaemic surgical patients, the impact of iron deficiency (ID) and its treatment in non-anaemic patients remains unclear.

Methods

In this single-centre retrospective analysis, non-anaemic ID patients (age ≥ 18 years) undergoing major cardiac surgery at the University Hospital Frankfurt were included. Primary endpoints were red blood cell (RBC) transfusion rate and use of RBC units. Secondary endpoints were increase in haemoglobin levels and postoperative outcome (mortality, length of stay, mechanical ventilation, laboratory values). Patients were assigned to the following groups: No-Iron (no anaemia, ID, and no iron supplementation) and Iron (anaemia, ID, and iron supplementation).

Results

A total of 3605 patients were screened, of whom 2345 were non-anaemic. Six hundred ninety-eight non-anaemic ID patients were included in the analysis, of whom 90 received intravenous iron supplementation. The overall RBC transfusion rate (43.6% [95% CI: 39.6–47.6] versus 50.0% [95% CI: 39.9–60.1]) and number of transfused blood units (2.0 [IQR: 1.0; 4.0] versus 2.0 [IQR: 1.0; 4.0]) were similar between patients of the No-Iron and Iron groups. Hospital length of stay, mortality, and postoperative complications were similar in both groups. When applying stricter cutoff values to define ID (ferritin < 30 μg/l), a trend toward reduced transfusion rates was observed: total RBC transfusion rate was 50.0% (95% CI: 34.9–65.2) in the No-Iron group and 42.9% (95% CI: 26.8–60.5) in the Iron group. In the case of short-term (1 day prior to surgery) iron supplementation, RBC unit utilisation and postoperative outcomes were comparable between the two groups.

Conclusion

In non-anaemic cardiac surgery patients, (short-term) preoperative intravenous iron supplementation showed no significant impact on RBC transfusion rate, haemoglobin levels, or postoperative outcomes. However, a stricter definition of ID revealed a trend toward reduced transfusion rates.